Germany
· Delayed Price · Currency is EUR Edwards Lifesciences Statistics
Total Valuation
ETR:EWL has a market cap or net worth of EUR 36.63 billion. The enterprise value is 33.78 billion.
| Market Cap | 36.63B |
| Enterprise Value | 33.78B |
Important Dates
The next estimated earnings date is Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.66% |
| Shares Change (QoQ) | -1.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 579.69M |
Valuation Ratios
The trailing PE ratio is 9.08.
| PE Ratio | 9.08 |
| Forward PE | n/a |
| PS Ratio | 6.97 |
| PB Ratio | 3.77 |
| P/TBV Ratio | 5.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.98, with an EV/FCF ratio of 120.65.
| EV / Earnings | 8.38 |
| EV / Sales | 7.03 |
| EV / EBITDA | 22.98 |
| EV / EBIT | 25.82 |
| EV / FCF | 120.65 |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.18 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.42 |
| Debt / FCF | 2.41 |
| Interest Coverage | 74.78 |
Financial Efficiency
Return on equity (ROE) is 16.64% and return on invested capital (ROIC) is 10.19%.
| Return on Equity (ROE) | 16.64% |
| Return on Assets (ROA) | 8.26% |
| Return on Invested Capital (ROIC) | 10.19% |
| Return on Capital Employed (ROCE) | 12.82% |
| Revenue Per Employee | 332,532 |
| Profits Per Employee | 255,205 |
| Employee Count | 15,800 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.02% |
| 50-Day Moving Average | 66.43 |
| 200-Day Moving Average | 66.11 |
| Relative Strength Index (RSI) | 41.09 |
| Average Volume (20 Days) | 512 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.00 |
Income Statement
In the last 12 months, ETR:EWL had revenue of EUR 5.25 billion and earned 4.03 billion in profits. Earnings per share was 6.73.
| Revenue | 5.25B |
| Gross Profit | 4.17B |
| Operating Income | 1.43B |
| Pretax Income | 1.50B |
| Net Income | 4.03B |
| EBITDA | 1.58B |
| EBIT | 1.43B |
| Earnings Per Share (EPS) | 6.73 |
Balance Sheet
The company has 3.84 billion in cash and 676.13 million in debt, giving a net cash position of 3.17 billion.
| Cash & Cash Equivalents | 3.84B |
| Total Debt | 676.13M |
| Net Cash | 3.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.72B |
| Book Value Per Share | 16.41 |
| Working Capital | 4.62B |
Cash Flow
In the last 12 months, operating cash flow was 523.81 million and capital expenditures -243.79 million, giving a free cash flow of 280.01 million.
| Operating Cash Flow | 523.81M |
| Capital Expenditures | -243.79M |
| Free Cash Flow | 280.01M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.46%, with operating and profit margins of 27.22% and 76.75%.
| Gross Margin | 79.46% |
| Operating Margin | 27.22% |
| Pretax Margin | 28.46% |
| Profit Margin | 76.75% |
| EBITDA Margin | 30.07% |
| EBIT Margin | 27.22% |
| FCF Margin | 5.33% |
Dividends & Yields
ETR:EWL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.66% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 11.01% |
| FCF Yield | 0.76% |
Stock Splits
The last stock split was on May 28, 2010. It was a forward split with a ratio of 2.
| Last Split Date | May 28, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
ETR:EWL has an Altman Z-Score of 12.13.
| Altman Z-Score | 12.13 |
| Piotroski F-Score | n/a |